Stock Analysis
Genius Sports Limited (GENI) Stock Analysis
Genius Sports Limited (GENI) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Genius Sports Limited (GENI) currently has an AIQ Score of 36/100, indicating a bearish setup. Value is the strongest factor at 48/100. Risk is the weakest current factor at 22/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
GENI at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $6.36 |
| AIQ Score | 36/100 |
| Overall View | Bearish |
| Technical Analysis Consensus | Neutral |
| Market Cap | $1.85B |
| P/E Ratio (TTM) | -10.57 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | -$0.28 |
| Revenue (quarter ended 2026-06-30) | $195.5M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 1.88 |
| Volume | 7.43M |
| 52-week range | $3.83-$11.98 |
| RSI 14 | 46.39 |
| 50-Day SMA | $6.70 |
| 200-Day SMA | $6.26 |
| Analyst Price Target | $10.27 |
| Next Earnings | Nov 5, 2026 |
GENIGenius Sports Limited
Communication Services / Internet Content & Information
Low Priority
Relative Laggard
Latest quote
- Momentum45
- Value48
- Quality24
- Risk resilience22
- Sentiment—
GENI Stock Analysis Summary
Genius Sports Limited (GENI) currently has an AIQ Score of 36/100, indicating a bearish setup. Value is the strongest factor at 48/100. Risk resilience is the weakest current factor at 22/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bearish regime, GENI has AIQ Score of 36/100 with Value base of 48/100 and fading Risk resilience at 22/100. Wait for component alignment before adding exposure.
Value (48/100) leads while Risk resilience (22/100) lags. This cross-factor spread creates entry timing uncertainty.
Communication Services · -1.55% stock move · GENI classified in Internet Content & Information.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is GENI Bullish or Bearish Right Now?
GENI currently has a bearish overall setup. Value is the strongest factor at 48/100, while Risk Resilience is weakest at 22/100. The current evidence suggests a defensive setup.
- - Analyst target implies +61.48% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (21 vs 15).
- - Risk Resilience is weak at 22/100.
Current Consensus
GENI's Technical Analysis Consensus is currently Neutral, with 21 buy, 9 neutral, and 15 sell votes. GENI's 14-day RSI is 46.39, which places the stock in a neutral momentum range. GENI's beta is 1.88, indicating greater market sensitivity than the broad market.
What Changed in GENI?
The largest recent change in GENI is Momentum moving down by 12.0 points over the available 7-day comparison window. Value remains the strongest visible factor.
What Would Change the GENI Outlook?
The current bearish outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
GENI Decision Framework
Public evidence layers, setup checks, and risk context for Genius Sports Limited.
Genius Sports Limited (GENI) Stock Analysis
Genius Sports Limited has an AIQ Score of 36/100 in a Defensive regime. Value is strongest at 48/100. Beta is 1.91, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | GENI is in a Defensive AIQ regime with score 36/100. |
| Signal Conflict | The primary conflict is that value leads at 48/100 while risk lags at 22/100. |
| Factor Evidence | Momentum 45/100 · Value 48/100 · Quality 24/100 · Risk 22/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 48/100.
Momentum is 45/100 and RSI (14) is 46.4.
GENI is in a Defensive regime at 36/100.
Risk factor is 22/100 with beta 1.91 and annual volatility 73.78%.
Current conflict: value leads at 48/100 while risk lags at 22/100.
GENI Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
GENI Fundamentals
GENI valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
GENI Technical Analysis
GENI technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
GENI Stock Catalysts
Track GENI earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
GENI Dividend Analysis
GENI dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
GENI Financial Data
GENI revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
GENI Risk Analysis
GENI volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
GENI Stock News
GENI stock news, market tone, recent headlines, and catalyst context.
GENI vs Internet / Consumer Tech Peers
Current peer cohort: GENI · IQ · MGNI · MTCH · NFLX. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| GENI Current stock | 36/100 | 48/100 | 45/100 | 22/100 | -0.49 | 73.78% | Current |
| IQ iQIYI | 36/100 | 65/100 | 25/100 | 27/100 | -1.89 | 50.32% | GENI vs IQ |
| MGNI Magnite | 43/100 | 29/100 | 31/100 | 33/100 | 0.54 | 57.74% | GENI vs MGNI |
| MTCH Match Group | 56/100 | 50/100 | 66/100 | 44/100 | 0.92 | 32.64% | GENI vs MTCH |
| NFLX Netflix | 48/100 | 33/100 | 23/100 | 45/100 | -1.53 | 35.92% | GENI vs NFLX |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching GENI
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for GENI
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
GENI Stock FAQ
What is GENI stock price today?
Genius Sports Limited's current stock price is $6.36. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is GENI bullish or bearish right now?
GENI's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is GENI's market cap?
GENI's market cap is $1.85B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is GENI's current P/E ratio?
GENI's current P/E ratio is -10.57 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is GENI's RSI?
GENI's 14-day RSI is 46.39 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is GENI above its 50-day and 200-day moving averages?
GENI is -3.53% from its 50-day SMA and 3.22% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is GENI's next earnings date?
GENI's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does GENI pay a dividend?
GENI's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.